OQS
Occudo Quantitative Strategies Portfolio holdings
AUM
$891M
1-Year Return
19.89%
This Quarter Return
-4.82%
1 Year Return
+19.89%
3 Year Return
+77.46%
5 Year Return
–
10 Year Return
–
AUM
$1.19B
AUM Growth
+$65.2M
(+5.8%)
Cap. Flow
+$122M
Cap. Flow
% of AUM
10.2%
Top 10 Holdings %
Top 10 Hldgs %
5.3%
Holding
1,418
New
379
Increased
331
Reduced
359
Closed
313
Top Buys
| 1 |
Patterson-UTI
PTEN
|
+$6.43M |
| 2 |
3M
MMM
|
+$6.39M |
| 3 |
Merck
MRK
|
+$6.3M |
| 4 |
Gilead Sciences
GILD
|
+$6.21M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$6M |
Top Sells
| 1 |
Chegg
CHGG
|
+$6.55M |
| 2 |
Intercontinental Exchange
ICE
|
+$5.8M |
| 3 |
Marvell Technology
MRVL
|
+$5.73M |
| 4 |
Varonis Systems
VRNS
|
+$5.65M |
| 5 |
Schlumberger
SLB
|
+$5.57M |
Sector Composition
| 1 | Technology | 20.62% |
| 2 | Industrials | 13.62% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Healthcare | 13.03% |
| 5 | Financials | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
AXT Inc
AXTI
$158M
| $126K | 0.01% |
17,934
-7,216
| -29% | -$50.7K |
|
|
ATNX
1002
DELISTED
Athenex, Inc. Common Stock
ATNX
| $126K | 0.01% |
7,599
| – | – |
|
1003
The ONE Group
STKS
$82.7M
| $122K | 0.01% |
11,602
-3,956
| -25% | -$41.6K |
|
1004
TETRA Technologies
TTI
$632M
| $120K | 0.01% |
+29,171
| New | +$120K |
|
1005
Cantaloupe
CTLP
$795M
| $119K | 0.01% |
17,595
-1,589
| -8% | -$10.7K |
|
1006
Finance of America Companies
FOA
$279M
| $118K | 0.01% |
3,888
-4,901
| -56% | -$149K |
|
1007
Loop Industries
LOOP
$89.7M
| $118K | 0.01% |
+13,223
| New | +$118K |
|
1008
Talkspace
TALK
$429M
| $117K | 0.01% |
67,005
+2,810
| +4% | +$4.91K |
|
1009
inTEST
INTT
$89.2M
| $113K | 0.01% |
10,485
| – | – |
|
|
EBET
1010
DELISTED
EBET, INC. Common Stock
EBET
| $112K | 0.01% |
+555
| New | +$112K |
|
1011
Korro Bio
KRRO
$327M
| $110K | 0.01% |
1,037
+581
| +127% | +$61.6K |
|
1012
VistaGen Therapeutics
VTGN
$110M
| $110K | 0.01% |
2,965
| – | – |
|
1013
Voyager Therapeutics
VYGR
$235M
| $110K | 0.01% |
+14,393
| New | +$110K |
|
1014
Advent Technologies
ADN
$8.54M
| $108K | 0.01% |
1,558
+547
| +54% | +$37.9K |
|
1015
Opko Health
OPK
$1.14B
| $106K | 0.01% |
30,943
-27,958
| -47% | -$95.8K |
|
1016
Shattuck Labs
STTK
$88.6M
| $106K | 0.01% |
+24,941
| New | +$106K |
|
1017
Adverum Biotechnologies
ADVM
$70.5M
| $105K | 0.01% |
8,008
-4,472
| -36% | -$58.6K |
|
1018
Astria Therapeutics
ATXS
$422M
| $103K | 0.01% |
15,341
-116
| -0.8% | -$779 |
|
1019
Vera Bradley
VRA
$66.5M
| $103K | 0.01% |
13,432
-5,604
| -29% | -$43K |
|
1020
Remitly
RELY
$3.97B
| $102K | 0.01% |
+10,362
| New | +$102K |
|
|
IVC
1021
DELISTED
Invacare Corporation
IVC
| $100K | 0.01% |
71,168
-31,887
| -31% | -$44.8K |
|
|
VIRX
1022
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $93K | 0.01% |
19,605
-13,046
| -40% | -$61.9K |
|
1023
Advantage Solutions
ADV
$593M
| $92K | 0.01% |
14,355
-12,581
| -47% | -$80.6K |
|
|
BCEL
1024
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $91K | 0.01% |
28,842
-49,433
| -63% | -$156K |
|
1025
Target Hospitality
TH
$864M
| $90K | 0.01% |
+14,966
| New | +$90K |
|